• Pharmacokinetic Variability of CSBTA in MASH: Insights for D

  2026-06-02

  This study presents a detailed pharmacokinetic and tissue distribution analysis of Corydalis saxicola Bunting total alkaloids (CSBTA) in mouse models of metabolic dysfunction-associated steatohepatitis (MASH), revealing how disease state and dosing frequency influence systemic exposure and hepatic accumulation. The findings highlight the importance of transporter and enzyme modulation in optimizing CSBTA-based interventions for MASLD/MASH.

• Technical Use of Angiotensin I/II (1-5) in RAS Modeling

  2026-06-01

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled modeling of the renin-angiotensin system in cardiovascular and renal workflows. It is suited for research on blood pressure regulation and aldosterone signaling, but should not be used outside these domains or in exploratory peptide signaling studies.

• Applied Workflows with Acetylspiramycin (Spiramycin B) in An

  2026-06-01

  Harness the dual antimicrobial and immunomodulatory properties of Acetylspiramycin (Spiramycin B) for cutting-edge resistance studies and host-pathogen investigations. This guide details robust experimental workflows, troubleshooting strategies, and cross-domain insights grounded in recent clinical and laboratory research.

• Sodium Ascorbate: Advanced Protocols for Glioblastoma Resear

  2026-05-31

  Sodium Ascorbate, a mineral salt of ascorbic acid, sets itself apart with its unique solubility profile and proven ability to induce intracellular ROS, making it a powerhouse for translational glioblastoma research. This guide delivers stepwise protocols, troubleshooting, and experimental strategies that harness its mechanistic advantages for reliable cancer cell assays.

• Fosinopril Sodium: Optimized ACE Inhibitor Workflows in Hype

  2026-05-30

  Fosinopril sodium distinguishes itself in hypertension and cardiovascular disease research through robust dual elimination pathways and a unique phosphinic acid ACE inhibition mechanism. This article provides actionable protocol enhancements, advanced applications, and troubleshooting guidance, empowering researchers to maximize reproducibility using APExBIO’s high-purity compound.

• Acridine Orange hydrochloride: Technical Guide for Nucleic A

  2026-05-29

  Acridine Orange hydrochloride is a dual-fluorescent dye enabling precise differentiation of DNA and RNA in situ, supporting workflows like cell cycle analysis, apoptosis detection, and flow cytofluorometric nucleic acid staining. It is not recommended for long-term storage of prepared solutions or for applications outside nucleic acid staining. This article summarizes practical use, protocol parameters, and troubleshooting strategies for research labs.

• KX2-391 Dihydrochloride: Systems Biology of Dual Inhibition

  2026-05-29

  Explore KX2-391 dihydrochloride's dual mechanism as both a Src kinase and tubulin polymerization inhibitor. This article uniquely analyzes its systems-level impact on signaling networks, guided by recent scientific discoveries and practical assay insights.

• Applied Workflows with Angiotensin 1/2 (2-7) Peptide

  2026-05-28

  Angiotensin 1/2 (2-7) peptide opens new frontiers for modeling blood pressure regulation and viral receptor interactions. This article distills advanced protocols, troubleshooting tactics, and cross-domain insights for maximizing research reproducibility and impact.

• WM-8014: Precision KAT6A Inhibitor for Epigenetic Assays

  2026-05-28

  WM-8014 offers unmatched selectivity and reversible inhibition of KAT6A/B, enabling researchers to dissect oncogene-induced senescence and cell cycle arrest with minimal cytotoxicity. This article provides hands-on guidance for deploying WM-8014 in advanced epigenetic and cancer biology workflows, with troubleshooting tips to maximize experimental success.

• HotStart Universal 2X Green qPCR Master Mix: Workflow Advanc

  2026-05-27

  Leveraging the HotStart Universal 2X Green qPCR Master Mix unlocks precise, high-efficiency gene expression analysis for complex models such as diabetic wound healing. Its antibody-mediated hot-start and universal ROX compatibility streamline setup, reduce troubleshooting, and ensure data reliability—making it indispensable for advanced biomedical research.

• Acetoacetic Acid Sodium Salt in Energy Metabolism Research

  2026-05-27

  Acetoacetic acid sodium salt (sodium 3-oxobutanoate) is transforming energy metabolism and diabetes research with its high purity, robust solubility, and validated role as a ketone body metabolite. This article breaks down practical protocols, advanced applications, and troubleshooting strategies that maximize reproducibility and translational impact, leveraging APExBIO’s rigorously benchmarked reagent.

• Precision Cell Assays: Otilonium Bromide for Reliable Result

  2026-05-26

  This scenario-driven guide equips biomedical researchers with validated strategies for cell-based assays using Otilonium Bromide (SKU B1607). By analyzing real-world workflow challenges, it demonstrates how this antimuscarinic agent from APExBIO enhances reproducibility, solubility, and confidence in cholinergic signaling research.

• Acetoacetic Acid Sodium Salt in Energy Metabolism Research

  2026-05-26

  Acetoacetic acid sodium salt (sodium 3-oxobutanoate) stands out as a robust, high-purity ketone body metabolite for dissecting energy metabolism and diabetes-associated pathways. This guide explores advanced protocol optimizations, real-world troubleshooting, and translational workflows that empower researchers to achieve high-fidelity, reproducible results in metabolic studies.

• Gut-Brain Cholinergic Pathway Mediates Antiseizure Effects o

  2026-05-25

  Jia et al. demonstrate that Bacteroides fragilis suppresses seizures in pediatric refractory epilepsy by activating a gut-vagus-brain cholinergic signaling pathway. Their findings establish a mechanistic link between intestinal microbiota, acetylcholine neurotransmitter signaling, and seizure control, offering a foundation for microbiota-targeted interventions.

• SB525334 and TGF-β1 Inhibition: Redefining Translational Pat

  2026-05-25

  This article explores the mechanistic and translational dimensions of TGF-β1 signaling modulation in fibrosis and chronic wound repair, centering on the use of SB525334. By synthesizing recent osteo-immune coupling insights with strategic experimental guidance, it positions SB525334 as an essential tool for researchers advancing from molecular validation to preclinical translation in complex tissue models.

16094 records 1/1073 page Next 12345 下5页 Last page